Walsh Robert F. III 4
4 · INTREXON CORP · Filed Jul 2, 2019
Insider Transaction Report
Form 4
Walsh Robert F. III
SVP, Energy & Fine Chem.
Transactions
- Exercise/Conversion
Common Stock
[F1]2019-06-30+14,341→ 33,823 total - Sale
Common Stock
[F2]2019-07-01$7.76/sh−5,007$38,854→ 28,816 total - Exercise/Conversion
Restricted Stock Units
[F1][F3]2019-06-30−14,341→ 43,021 total→ Common Stock (14,341 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of XON common stock.
- [F2]This sale was effected pursuant to the terms of a 10b5-1 plan adopted by the reporting person and was made in order to pay the tax liability arising from the vesting of restricted stock units.
- [F3]The restricted stock units were granted on April 9, 2019, and the remaining restricted stock units vest in three equal quarterly installments on each of September 30, 2019, December 31, 2019 and March 31, 2020.
Signature
/s/ Robert F. Walsh, III, by Donald P. Lehr, as attorney-in-fact|2019-07-02